Looking for Sentiment Analysis? Discover the most popular stocks on Reddit by using our Sentiment Tracker
Market Cap 0.94B P/E 39.73 EPS this Y -100.00% Ern Qtrly Grth -
Income -790k Forward P/E -490.00 EPS next Y - 50D Avg Chg 1.00%
Sales 243.62M PEG - EPS past 5Y - 200D Avg Chg 47.00%
Dividend N/A Price/Book 2.90 EPS next 5Y - 52W High Chg -
Recommedations 2.30 Quick Ratio 0.94 Shares Outstanding 64.13M 52W Low Chg 129.00%
Insider Own 0.08% ROA -3.19% Shares Float 37.39M Beta 0.76
Inst Own 77.31% ROE -0.25% Shares Shorted/Prior 229.45K/77.63K Price 14.70
Gross Margin 54.31% Profit Margin -0.32% Avg. Volume 380,440 Target Price 18.67
Oper. Margin -16.69% Earnings Date Mar 2 Volume 2,389,430 Change 0.00%
About Amryt Pharma plc

Amryt Pharma plc, a commercial-stage biopharmaceutical company, focuses on acquiring, developing, and commercializing various treatments to help improve the lives of patients with rare and orphan diseases. The company provides metreleptin, an adjunct to diet as replacement therapy to treat the complications of leptin deficiency in patients with congenital or acquired generalized lipodystrophy; oral octreotide, a long-term maintenance therapy in acromegaly patients; and lomitapide, an adjunct to a low-fat diet and other lipid-lowering medicinal products for adults with the Homozygous familial Hypercholesteraemia. Its development candidates include Oleogel-S10 for the cutaneous manifestations of Junctional and Dystrophic Epidermolysis Bullosa (EB), a rare and distressing genetic skin disorder affecting young children and adults; and AP103, a pre-clinical gene therapy for patients with dystrophic EB. The company sells its products in the Americas, Europe, and the Middle East. Amryt Pharma plc was founded in 2015 and is headquartered in Dublin, Ireland.

AMYT Chatroom

User Image Eugene_O Posted - 1 month ago

$AMYT Fidelity just deposited the money from both CVRs just before market close. Waiting on Merrill.

User Image Eugene_O Posted - 1 month ago

$AMYT It looks like any bank holiday in either Dublin, London or New York does not count as a business day. Dublin has Feb 1st, London Dec 26th an New York has Feb 12th as extra days closed. So it seems the payout date will be February 20th.

User Image Chrono_Z Posted - 1 month ago

$AMYT Have they shared any details on CVR payout following approval?

User Image kuda8 Posted - 2 months ago

$AMYT Thanks , bad news for STS101 Satsuma .

User Image Eugene_O Posted - 2 months ago

$AMYT Found the answer. Payments will be made for the Milestone 1 CVR based on the approval. Milestone 2 is also met. Congrats everyone. https://chiesirarediseases.com/media/fda-approval-for-filsuvez-topical-gel

User Image Eugene_O Posted - 2 months ago

$AMYT So does this apply? § 314.510 Approval based on a surrogate endpoint or on an effect on a clinical endpoint other than survival or irreversible morbidity. FDA may grant marketing approval for a new drug product on the basis of adequate and well-controlled clinical trials establishing that the drug product has an effect on a surrogate endpoint that is reasonably likely, based on epidemiologic, therapeutic, pathophysiologic, or other evidence, to predict clinical benefit or on the basis of an effect on a clinical endpoint other than survival or irreversible morbidity. Approval under this section will be subject to the requirement that the applicant study the drug further, to verify and describe its clinical benefit, where there is uncertainty as to the relation of the surrogate endpoint to clinical benefit, or of the observed clinical benefit to ultimate outcome. Postmarketing studies would usually be studies already underway.

User Image Eugene_O Posted - 2 months ago

$AMYT It looks like the approval for DEB includes the Recessive type required for Milestone 1 and was granted under Priority Review but not Accelerated Approval, and so seems that the conditions were met. "DEB usually presents itself at birth and is divided into two major types depending on the inheritance pattern: recessive dystrophic epidermolysis bullosa (RDEB) and dominant dystrophic epidermolysis bullosa (DDEB)."

User Image Eugene_O Posted - 2 months ago

$AMYT Does the approval for dystrophic epidermolysis bullosa include the recessive type? “Milestone 1” means an approval issued by the FDA for Filsuvez, with any such approval to include a labelled indication related to wound healing in patients with recessive dystrophic epidermolysis bullosa (or a broader indication)"

User Image Eugene_O Posted - 2 months ago

$AMYT

User Image Eugene_O Posted - 2 months ago

$AMYT does not appear on the "Accelerated Approval" list.

User Image Eugene_O Posted - 2 months ago

$AMYT Filsuvez was designated "Priority Review".

User Image kuda8 Posted - 2 months ago

$AMYT “Milestone 1” means an approval issued by the FDA for Filsuvez, with any such approval to include a labelled indication related to wound healing in patients with recessive dystrophic epidermolysis bullosa (or a broader indication) at any time on or akter the date of the Transaction Agreement or prior to the relevant Milestone Deadline Date; provided that such approval is not granted by the FDA under 21 C.F.R. §§ 314.510 of FDA’s regulations (i.e., accelerated approval). It seems FDA granted under 21 CFR , will ask their Lawyer Dechert in charge of the deal .

User Image Eugene_O Posted - 2 months ago

$AMYT Looking good for both these CVRs. How many CVR holders on here? "CVRs of up to US $2.50 per ADS are payable if certain milestones related to Amryt’s product Filsuvez® are achieved before December 31, 2024, consisting of US$1.00 per ADS upon FDA approval of Filsuvez® and US$1.50 per ADS upon successful receipt of a Priority Review Voucher from the FDA."

User Image Eugene_O Posted - 2 months ago

$AMYT Need to read the fine print of the CVR terms but haven't been able to find it. https://www.globenewswire.com/news-release/2023/12/19/2798751/0/en/Chiesi-Global-Rare-Diseases-Receives-FDA-Approval-for-FILSUVEZ-birch-triterpenes-topical-gel-for-the-Treatment-of-Epidermolysis-Bullosa.html

User Image Eugene_O Posted - 2 months ago

$AMYT Both CVRs are valid it appears.

User Image kuda8 Posted - 3 months ago

$AMYT Chiesi got FDA aproval for Filsuvez , good for the first CVR ?

User Image STCKPRO Posted - 4 months ago

$AMYT NEW ARTICLE : Poolbeg Pharma beefs up leadership; brings key players from succesful Amryt Pharma team https://www.stck.pro/news/AMYT/66947184/

User Image TrendyChart Posted - 5 months ago

Upcoming Earnings Report: $AMYT Amryt Pharma will be reporting on 11/06/2023 at 7:00AM | Are you expecting earnings to be above or below expectations?

User Image TrendyChart Posted - 5 months ago

Upcoming Earnings Report: $AMYT Amryt Pharma will be reporting on 11/02/2023 at 7:00AM | Are you bullish or bearish on earnings for this stock?

User Image StillnessofBreath Posted - 10 months ago

$AKBA I was just reading $AMYT filed FDRR around us or even later than us. They got acquired without the result out!

User Image tickeron Posted - 10 months ago

Amryt Pharma plc to report earnings on May 03, 2023. Earnings per share (EPS) estimate: $-0.01 $AMYT https://srnk.us/go/4621556

User Image Nostradamus696 Posted - 11 months ago

$TRIL $AMYT $CINC $HZNP have had great fortune being a part of the some of the best biotech acquisitions of all time. Altimmune is next!!

User Image Quantisnow Posted - 11 months ago

$AMYT New live insights: 1. 📜 SEC Form EFFECT filed by Amryt Pharma plc https://quantisnow.com/i/4370098?utm_source=stocktwits 2. 📜 SEC Form 15F-12B filed by Amryt Pharma plc https://quantisnow.com/i/4370103?utm_source=stocktwits 3. 📜 SEC Form EFFECT filed by Amryt Pharma plc https://quantisnow.com/i/4370106?utm_source=stocktwits #healthcare

User Image stockilluminati Posted - 11 months ago

$AMYT https://www.stockilluminati.com/amyt/filings.php - Amryt Pharma plc - American Depositary Shares files form EFFECT today, check out the details.

User Image risenhoover Posted - 11 months ago

$AMYT / Amryt Pharma Plc - ADR files form 15F-12B https://fintel.io/sf/us/amyt?utm_source=stocktwits.com&utm_medium=referral&utm_campaign=filing

User Image Quantisnow Posted - 11 months ago

$AMYT 📜 SEC Form EFFECT filed by Amryt Pharma plc https://quantisnow.com/i/4370097?utm_source=stocktwits 45 seconds delayed.

User Image fla Posted - 11 months ago

$AMYT [15s. delayed] filed form 15F-12B on April 24, 06:00:57 https://s.flashalert.me/U97LNK

User Image fla Posted - 11 months ago

$AMYT [15s. delayed] filed form EFFECT on April 24, 00:15:20 https://s.flashalert.me/EaSZI

User Image fla Posted - 11 months ago

$AMYT [15s. delayed] filed form EFFECT on April 24, 00:15:24 https://s.flashalert.me/S9bgb

User Image fla Posted - 11 months ago

$AMYT [15s. delayed] filed form EFFECT on April 24, 00:15:11 https://s.flashalert.me/xOujUj

Analyst Ratings
HC Wainwright & Co. Neutral Jan 18, 23
Maxim Group Hold Jan 10, 23
Cantor Fitzgerald Neutral Jan 10, 23
Canaccord Genuity Hold Jan 10, 23
SVB Leerink Market Perform Jan 9, 23
SVB Leerink Outperform Jun 24, 22
SVB Leerink Outperform May 5, 22
HC Wainwright & Co. Buy Mar 10, 22
SVB Leerink Outperform Mar 10, 22